Search research articles
Contact Us
Filters
Showing results (81-90 of 113) with videos related to
Page
of 12
Sort By:
Lancet (London, England)
|
October 31, 2021
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study
Raphael Sonabend, Lilith K Whittles, Natsuko Imai, et al.
The Lancet. Global Health
|
November 22, 2024
Lassa fever outbreaks, mathematical models, and disease parameters: a systematic review and meta-analysis
Patrick Doohan, David Jorgensen, Tristan M Naidoo, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
April 12, 2017
Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013-2016
Tini Garske, Anne Cori, Archchun Ariyarajah, et al.
Scientific Reports
|
August 12, 2021
Comparing the responses of the UK, Sweden and Denmark to COVID-19 using counterfactual modelling
Swapnil Mishra, James A Scott, Daniel J Laydon, et al.
The Lancet. HIV
|
November 4, 2022
Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa (the HPTN 071 [PopART] trial): a modelling study
William J M Probert, Rafael Sauter, Michael Pickles, et al.
The Lancet. Infectious Diseases
|
June 9, 2026
Estimation of the Ebola outbreak size in the Democratic Republic of the Congo
Ruth McCabe, Lennox Ebbarnezh, Solome Okware, et al.
Epidemics
|
June 15, 2014
OutbreakTools: a new platform for disease outbreak analysis using the R software
Thibaut Jombart, David M Aanensen, Marc Baguelin, et al.
The Lancet. HIV
|
July 1, 2021
Age patterns of HIV incidence in eastern and southern Africa: a modelling analysis of observational population-based cohort studies
Kathryn A Risher, Anne Cori, Georges Reniers, et al.
The Lancet. Global Health
|
March 15, 2021
Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial
Ranjeeta Thomas, William J M Probert, Rafael Sauter, et al.
The Lancet. Public Health
|
February 12, 2023
Quantifying the effect of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study
Natsuko Imai, Thomas Rawson, Edward S Knock, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 113) with videos related to
Sort By:
Page
of 12
Lancet (London, England)
|
October 31, 2021
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study
Raphael Sonabend, Lilith K Whittles, Natsuko Imai, et al.
The Lancet. Global Health
|
November 22, 2024
Lassa fever outbreaks, mathematical models, and disease parameters: a systematic review and meta-analysis
Patrick Doohan, David Jorgensen, Tristan M Naidoo, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
April 12, 2017
Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013-2016
Tini Garske, Anne Cori, Archchun Ariyarajah, et al.
Scientific Reports
|
August 12, 2021
Comparing the responses of the UK, Sweden and Denmark to COVID-19 using counterfactual modelling
Swapnil Mishra, James A Scott, Daniel J Laydon, et al.
The Lancet. HIV
|
November 4, 2022
Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa (the HPTN 071 [PopART] trial): a modelling study
William J M Probert, Rafael Sauter, Michael Pickles, et al.
The Lancet. Infectious Diseases
|
June 9, 2026
Estimation of the Ebola outbreak size in the Democratic Republic of the Congo
Ruth McCabe, Lennox Ebbarnezh, Solome Okware, et al.
Epidemics
|
June 15, 2014
OutbreakTools: a new platform for disease outbreak analysis using the R software
Thibaut Jombart, David M Aanensen, Marc Baguelin, et al.
The Lancet. HIV
|
July 1, 2021
Age patterns of HIV incidence in eastern and southern Africa: a modelling analysis of observational population-based cohort studies
Kathryn A Risher, Anne Cori, Georges Reniers, et al.
The Lancet. Global Health
|
March 15, 2021
Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial
Ranjeeta Thomas, William J M Probert, Rafael Sauter, et al.
The Lancet. Public Health
|
February 12, 2023
Quantifying the effect of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study
Natsuko Imai, Thomas Rawson, Edward S Knock, et al.
Page
of 12